Drug
Tilrekimig clinical trials
Also written PF-07275315.
- studies test it
- 11
- open now
- 7
- in phase 3
- 6
- first study started
- 2022
Keep track of what changes. Save the tilrekimig studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2026 (7)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses tilrekimig is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingPhase 2/3PfizerNCT07363694Written as PF-07275315 dose 1
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruitingPhase 3PfizerNCT07783425Written as Tilrekimig
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruitingPhase 3PfizerNCT07765888Written as Tilrekimig
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaRecruitingPhase 2PfizerNCT06977581Written as PF-07275315
- A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe AsthmaRecruitingPhase 3PfizerNCT07869043Written as tilrekimig
- A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe AsthmaRecruitingPhase 3PfizerNCT07772921Written as tilrekimig
- A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of Chronic Obstructive Pulmonary Disease (COPD) to Learn About This Medicine When Used for a Long Period of TimeNot yet recruitingPhase 3PfizerNCT07839884Written as Tilrekimig
- A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisActive, not recruitingPhase 2PfizerNCT05995964Written as PF-07275315
- A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20Active, not recruitingPhase 1PfizerNCT07792941Written as tilrekimig and rHuPH20
- A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult ParticipantsCompletedPhase 1PfizerNCT06675188Written as PF-07275315
- A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy PeopleCompletedPhase 1PfizerNCT05411588Written as PF-07275315
Codes
What other systems call tilrekimig · ClinicalTrials.gg INT017166
- UNII (FDA) LD48NPB5QSTILREKIMIGOne source FDA
- NCI Thesaurus C211783TilrekimigOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LD48NPB5QS | TILREKIMIG | One source FDA |
| NCI Thesaurus | C211783 | Tilrekimig | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.